Biological Assembly 1  

 3D View: Structure | Electron Density | Ligand Interaction

Standalone Viewers  
Protein Workshop | Ligand Explorer

Global Symmetry: Cyclic - C2  (3D View)
Global Stoichiometry: Homo 2-mer - A2 

Biological assembly 1 assigned by authors and generated by PISA (software)

Macromolecule Content

• Total Structure Weight: 22466.74 
• Atom Count: 1668 
• Residue Count: 198 
• Unique protein chains: 1

5UOV

HIV-1 wild Type protease with GRL-1118A , an isophthalamide-derived P2-P3 ligand with the sulfonamide isostere as the P2' group

• DOI: 10.2210/pdb5UOV/pdb

• Classification: hydrolase/hydrolase inhibitor
• Organism(s): Human immunodeficiency virus type 1 group M subtype B
• Expression System: Escherichia coli BL21(DE3)
• Mutation(s): 5 


• Deposited: 2017-02-01 Released: 2017-05-10 
• Deposition Author(s): Wang, Y.-F., Agniswamy, J., Weber, I.T.
• Funding Organization(s): National Institutes of Health/National Institute of General Medical Sciences; Department of Energy (United States); National Institutes of Health/National Cancer Institute; Ministry of Education, Culture, Sports, Science and Technology (Japan); the Ministry of Health, Welfare, and Labor of Japan; Purdue University 

---

Experimental Data Snapshot

• Method: X-RAY DIFFRACTION
• Resolution: 1.33 Å
• R-Value Free: 0.183 
• R-Value Work: 0.152 

Literature

Design of novel HIV-1 protease inhibitors incorporating isophthalamide-derived P2-P3 ligands: Synthesis, biological evaluation and X-ray structural studies of inhibitor-HIV-1 protease complex.

Ghosh, A.K., Brindisi, M., Nyalapatla, P.R., Takayama, J., Ella-Menye, J.R., Yashchuk, S., Agniswamy, J., Wang, Y.F., Aoki, M., Amano, M., Weber, I.T., Mitsuya, H.

(2017) Bioorg. Med. Chem. 25: 5114-5127

• PubMed: 28434781 
• DOI: 10.1016/j.bmc.2017.04.005
• Primary Citation of Related Structures:  
  5UPZ


• PubMed Abstract: 
  

Based upon molecular insights from the X-ray structures of inhibitor-bound HIV-1 protease complexes, we have designed a series of isophthalamide-derived inhibitors incorporating substituted pyrrolidines, piperidines and thiazolidines as P2-P3 ligands for specific interactions in the S2-S3 extended site. Compound 4b has shown an enzyme Ki of 0.025nM and antiviral IC50 of 69nM. An X-ray crystal structure of inhibitor 4b-HIV-1 protease complex was determined at 1.33Å resolution. We have also determined X-ray structure of 3b-bound HIV-1 protease at 1.27Å resolution. These structures revealed important molecular insight into the inhibitor-HIV-1 protease interactions in the active site.

---

Organizational Affiliation: 

Department of Chemistry and Department of Medicinal Chemistry, Purdue University, West Lafayette, IN 47907, USA. Electronic address: [e-mail].

Macromolecules

Find similar proteins by: Sequence  |  Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details
Protease	A, B	99	Human immunodeficiency virus type 1 group M subtype B	Mutation(s): 5  Gene Names: gag-pol
Find proteins for P03366 (Human immunodeficiency virus type 1 group M subtype B) Go to UniProtKB:  P03366

Small Molecules

Ligands 5 Unique
ID	Chains	Name / Formula / InChI Key	2D Diagram & Interactions
NA	A	SODIUM ION Na FKNQFGJONOIPTF-UHFFFAOYSA-N
ACT	B	ACETATE ION C2 H3 O2 QTBSBXVTEAMEQO-UHFFFAOYSA-M
CL	A, B	CHLORIDE ION Cl VEXZGXHMUGYJMC-UHFFFAOYSA-M
GOL	A	GLYCEROL GLYCERIN; PROPANE-1,2,3-TRIOL C3 H8 O3 PEDCQBHIVMGVHV-UHFFFAOYSA-N
8FP	A	N-[(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]-3-[(2R)-2-(4-methyl-1,3-thiazol-2-yl)pyrrolidine-1-carbonyl]benzamide C37 H44 N4 O6 S2 ZHCCHBWXFODCGA-LBFZIJHGSA-N

Experimental Data & Validation

Experimental Data

• Method: X-RAY DIFFRACTION
• Resolution: 1.33 Å
• R-Value Free: 0.183 
• R-Value Work: 0.152 
• Space Group: P 2₁ 2₁ 2

Unit Cell:

Length (Å)	Angle (°)
a = 58.179	α = 90.00
b = 86.515	β = 90.00
c = 45.945	γ = 90.00

Software Package:

Software Name	Purpose
SHELXL-97	refinement
AMoRE	phasing
HKL-2000	data reduction
HKL-2000	data scaling

Structure Validation

Entry History & Funding Information

Deposition Data

• Deposited Date: 2017-02-01 
• Released Date: 2017-05-10 
• Deposition Author(s): Wang, Y.-F., Agniswamy, J., Weber, I.T.

---

Funding Organization	Country	Grant Number
National Institutes of Health/National Institute of General Medical Sciences	United States	GM53386
National Institutes of Health/National Institute of General Medical Sciences	United States	GM62920
Department of Energy (United States)	United States	W-31-109-Eng-38
National Institutes of Health/National Cancer Institute	United States	the Intramural Research Program of the Center for Cancer Research
Ministry of Education, Culture, Sports, Science and Technology (Japan)	Japan	a Grant-in-Aid for Scientific Research (Priority Areas)
the Ministry of Health, Welfare, and Labor of Japan	Japan	a Grant for Promotion of AIDS Research
Ministry of Education, Culture, Sports, Science and Technology (Japan)	Japan	the Grant to the Cooperative Research Project on Clinical and Epidemiological Studies of Emerging and Reemerging Infectious Diseases (Renkei Jigyo)
Purdue University	United States	the Purdue University Center for Cancer Research

Revision History 

• Version 1.0: 2017-05-10
  Type: Initial release
• Version 1.1: 2017-09-27
  Type: Author supporting evidence
• Version 1.2: 2017-10-04
  Type: Database references